BAY-2476568

N/A

Report date: 2026/05/08 20:02:52
NME

Base Information

Drug NameBAY-2476568
Drug Alias NameBAY-2476568BAY 2476568
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEGFR exon 20 insertion mutations inhibitorsEpidermal growth factor receptor erbB1 inhibitors
TargetsEpidermal growth factor receptor erbB1EGFR exon 20 insertion mutations
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBayer AGBroad InstituteHarvard University
China Registration ClassN/A

Develop Information

Active CompaniesBroad InstituteHarvard UniversityBayer AG
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A